J. Fominaya

发表

Membrane localization of all class I PI 3‐kinase isoforms suppresses c‐Myc‐induced apoptosis in Rat1 fibroblasts via Akt

W. Link, A. Carnero, Aránzazu Rosado, 2005, Journal of cellular biochemistry.

An optimized amphiphilic cationic peptide as an efficient non‐viral gene delivery vector

M. Gasset, A. Bernad, J. Fominaya, 2000, The journal of gene medicine.

Discovery of mitogen-activated protein kinase-interacting kinase 1 inhibitors by a comprehensive fragment-oriented virtual screening approach.

O. Rabal, J. Oyarzábal, Manuel Urbano-Cuadrado, 2010, Journal of medicinal chemistry.

Enhanced serum proteolysis resistance of cell-penetrating peptides.

J. Bravo, A. Rebollo, J. Fominaya, 2015, Therapeutic delivery.

Strategies to stabilize cell penetrating peptides for in vivo applications.

J. Bravo, A. Rebollo, J. Fominaya, 2015, Therapeutic delivery.

Exploring cellular senescence as a tumor suppressor mechanism

Juan F. Martínez, W. Link, O. Renner, 2003, Revista de Oncología.

Hit to lead evaluation of 1,2,3-triazolo[4,5-b]pyridines as PIM kinase inhibitors.

J. Oyarzábal, J. Fominaya, N. Ajenjo, 2012, Bioorganic & medicinal chemistry letters.

Spinophilin acts as a tumor suppressor by regulating Rb phosphorylation

S. Peregrina, A. Carnero, J. Fominaya, 2011, Cell cycle.

Oxidation of Sulfhydryl Groups of Ribonuclease Inhibitor in Epithelial Cells Is Sufficient for Its Intracellular Degradation*

J. Hofsteenge, J. Fominaya, Montserrat Blázquez, 1996, The Journal of Biological Chemistry.

On the degradation of intracellular RNA by ribonucleases.

J. Gavilanes, J. Fominaya, J. García-Segura, 1986, The International journal of biochemistry.

Purification, molecular and enzymic characterization of an acid RNase from the insect Ceratitis capitata.

J. Gavilanes, J. Fominaya, J. García-Segura, 1986, European journal of biochemistry.

Alkaline ribonuclease from the insect Ceratitis capitata

J. Gavilanes, J. Fominaya, J. García-Segura, 1985 .

Polyadenylated-RNA during the development of Ceratitis capitata

J. Gavilanes, J. Fominaya, J. García-Segura, 1984 .

A Modular DNA Carrier Protein Based on the Structure of Diphtheria Toxin Mediates Target Cell-specific Gene Delivery*

W. Wels, C. Uherek, J. Fominaya, 1998, The Journal of Biological Chemistry.

Inactivation of ribonuclease inhibitor by thiol-disulfide exchange.

J. Hofsteenge, J. Fominaya, Jesus, 1992, The Journal of biological chemistry.

Inhibition of phosphatidylinositol-3-kinase synergizes with gemcitabine in low-passage tumor cell lines correlating with Bax translocation to the mitochondria

J. Leal, J. Velasco, A. Carnero, 2005, Anti-cancer drugs.

A chimeric fusion protein containing transforming growth factor-α mediates gene transfer via binding to the EGF receptor

W. Wels, C. Uherek, J. Fominaya, 1998, Gene Therapy.

MAP17 enhances the malignant behavior of tumor cells through ROS increase.

J. Leal, A. Carnero, J. Fominaya, 2007, Carcinogenesis.

Pim 1 kinase inhibitor ETP-45299 suppresses cellular proliferation and synergizes with PI3K inhibition.

J. Oyarzábal, J. Leal, J. Bischoff, 2011, Cancer letters.

Mst 1 , RanBP 2 and eIF 4 G are new markers for in vivo PI 3 K activation in murine and human prostate

J. Leal, O. Renner, A. Carnero, 2007 .

Rapid identification of ETP-46992, orally bioavailable PI3K inhibitor, selective versus mTOR.

M. Barbacid, F. Mulero, P. Pizcueta, 2012, Bioorganic & medicinal chemistry letters.

Identification of ETP-46321, a Potent and Orally Bioavailable PI3K α, δ Inhibitor.

M. Barbacid, F. Mulero, P. Pizcueta, 2012 .

Modular Fusion Proteins for Receptor-mediated Gene Delivery

W. Wels, C. Uherek, J. Fominaya, 1998 .

Effect of different baculovirus inactivation procedures on the integrity and immunogenicity of porcine parvovirus-like particles.

J. Fominaya, C. Vela, J. Casal, 2000, Vaccine.

Evaluation of Caspase-9b and PP2Acα2 as potential biomarkers for chronic lymphocytic leukemia

J. Bravo, A. Rebollo, J. Fominaya, 2016, Biomarker Research.

Biological characterization of ETP-46321 a selective and efficacious inhibitor of phosphoinositide-3-kinases

J. Bischoff, W. Link, S. Peregrina, 2013, Investigational New Drugs.

Chemical Interrogation of FOXO3a Nuclear Translocation Identifies Potent and Selective Inhibitors of Phosphoinositide 3-Kinases*

O. Rabal, J. Oyarzábal, J. Bischoff, 2009, The Journal of Biological Chemistry.

MAP17 overexpression is a common characteristic of carcinomas.

J. Leal, A. Carnero, J. Fominaya, 2007, Carcinogenesis.

Cellular senescence bypass screen identifies new putative tumor suppressor genes

D. Beach, J. Leal, S. Y. Cajal, 2008, Oncogene.

Mst1, RanBP2 and eIF4G are new markers for in vivo PI3K activation in murine and human prostate.

J. Leal, O. Renner, A. Carnero, 2007, Carcinogenesis.

Imidazo[1,2-a]pyrazines as novel PI3K inhibitors.

O. Rabal, J. Oyarzábal, J. Bischoff, 2012, Bioorganic & medicinal chemistry letters.

Target Cell-specific DNA Transfer Mediated by a Chimeric Multidomain Protein

W. Wels, J. Fominaya, 1996, The Journal of Biological Chemistry.

Ribonuclease-RNAase inhibitor complex from rat testis. Purification of the RNAase inhibitor.

J. Gavilanes, J. Fominaya, J. García-Segura, 1988, Biochimica et biophysica acta.

Identification of an immunodominant epitope in the C terminus of glycoprotein 5 of porcine reproductive and respiratory syndrome virus.

J. Fominaya, E. Cortés, J. Casal, 2001, The Journal of general virology.

Extreme sensitivity to Yondelis® (Trabectedin, ET‐743) in low passaged sarcoma cell lines correlates with mutated p53

J. Cigudosa, M. Piris, M. Sánchez-Beato, 2007, Journal of cellular biochemistry.

Characterization of the nucleolytic activity from the digestive juice of Ceratitis capitata larvae

J. Gavilanes, J. Fominaya, J. García-Segura, 1987 .

A new serotonin 2A receptor antagonist with potential benefits in Non-Alcoholic Fatty Liver Disease.

S. Concilio, X. Busquets, L. Sessa, 2022, Life sciences.

Identification of PP2A/Set Binding Sites and Design of Interacting Peptides with Potential Clinical Applications

J. Bravo, V. Janssens, A. Rebollo, 2018, International Journal of Peptide Research and Therapeutics.

Chapter 1 Piercing Lipid Bilayers with Peptides

M. Gasset, E. Goormaghtigh, J. Fominaya, 2006 .

Pim 1 kinase inhibitor ETP-45299 suppresses cellular proliferation and synergizes with PI3K inhibition.

J. Oyarzábal, J. Leal, J. Bischoff, 2011, Cancer letters.

Identification of ETP-46321, a potent and orally bioavailable PI3K α, δ inhibitor.

M. Barbacid, F. Mulero, P. Pizcueta, 2012, Bioorganic & medicinal chemistry letters.